We herein report a case of a ruptured vertebral artery dissecting aneurysm involving the origin of the posterior inferior cerebellar artery that was treated using the stent-jack technique. After parent artery occlusion of the distal vertebral artery, stenting of the posterior inferior cerebellar artery was performed. Further coiling was needed because distal vertebral artery recanalization occurred due to transformation of the coil mass. The stent-jack technique for a ruptured vertebral artery dissecting aneurysm involving the origin of the posterior inferior cerebellar artery is effective; however, careful attention to recanalization after stenting is needed due to transformation of the coil mass.
17 September 2025 in Journal of Stroke and Cerebrovascular Diseases
The optimal duration of dual antiplatelet therapy (DAPT) following carotid artery stenting (CAS) is unclear. Therefore, this study aimed to compare outcomes across four centers with differing DAPT strategies-3-month versus extended duration-to assess safety and efficacy. We retrospectively evaluated 347 patients who underwent CAS between 2010 and 2022. Patients were categorized into two groups according to DAPT duration:3 months or >3 months. We compared patient backgrounds, postoperative stroke events, and DAPT-related hemorrhagic complications. Propensity score matching was performed, and 80 matched pairs were analyzed. In the matched cohort of 80 pairs, the incidence of ischemic events, including cerebral infarction and transient ischemic attack, was four and 10 in the 3-month DAPT and >3-month DAPT groups, respectively. Intracranial and extracranial hemorrhagic events occurred in two and seven cases in the 3-month and >3-month groups, respectively. Log-rank testing showed a statistically significant association between >3-month DAPT and higher incidence of hemorrhagic complications (including intracranial and extracranial hemorrhage) (hazard ratio [HR]: 6.21, 95 % confidence interval [CI] 1.23-31.4, p=0.014), whereas no significant difference was observed in ischemic event rates (HR 2.90, 95 % CI 0.89-9.46, p=0.077). In our series of CAS patients treated with DAPT, a 3-month regimen before transitioning to SAPT was associated with similar efficacy and a lower incidence of hemorrhages compared to longer DAPT regimens. High-risk ischemic cases should be considered individually; however, routine extension of DAPT beyond 3 months may not be necessary.
1 May 2026 in Journal of Korean Neurosurgical Society
Objective : To evaluate the efficacy of individualized dual antiplatelet therapy (DAPT) using VerifyNow in reducing periprocedural ischemic complications following carotid artery stenting (CAS), particularly in patients with unstable plaques.Methods : This retrospective, single-center study included 187 patients who underwent elective CAS between January 2018 and September 2024. Patients were divided into two groups : a conventional DAPT (c-DAPT) group treated with aspirin and clopidogrel (n=89), and an individualized DAPT (i-DAPT) group (n=98) where antiplatelet regimens were adjusted based on preoperative platelet reactivity measured by VerifyNow. The primary outcome was the incidence of ischemic lesions on diffusion-weighted imaging (DWI) following CAS. Risk factors and the impact of DAPT personalization on ischemic changes were analyzed using multivariate logistic regression.Results : DWI-positive ischemic lesions were observed in 62.9% of the c-DAPT group and 51% of the i-DAPT group (p=0.07). Although the difference was not statistically significant, there was a trend toward reduced ischemic changes with individualized therapy. Multivariate analysis identified hypertension, diabetes mellitus, and unstable plaque as independent predictors of post-CAS ischemic changes. Subgroup analysis showed that VerifyNow-guided i-DAPT significantly reduced ischemic events in patients with unstable plaques (odds ratio, 0.49; p=0.03), whereas no significant effect was observed in other subgroups.Conclusion : VerifyNow-guided personalization of antiplatelet therapy is a safe and may have the potential to reduce periprocedural ischemic complications in CAS, particularly in patients with unstable plaques. Further multicenter prospective studies are needed to validate these findings and optimize individualized antiplatelet regimens.
15 November 2024 in Surgical Neurology International
Background: Vertebral artery (VA) stenosis can be caused by several factors, including arteriosclerosis, arterial dissection, and mechanical compression. Symptomatic vertebrobasilar insufficiency caused by VA stenosis due to mechanical compression associated with head rotation is well-known as Bow Hunter’s syndrome. However, an accurate diagnosis of asymptomatic osteophyte compression-induced nonrotational VA stenosis is difficult. We report a case of left posterior inferior cerebellar artery aneurysm with severe left VA stenosis, treated with stent-assisted coil embolization following appropriate diagnosis. Case Description: A 72-year-old female patient was found to have severe asymptomatic VA stenosis at the V2 segment (C4–5 level of the cervical spine) on cerebral angiography. Osteophyte compression-induced VA stenosis was suspected, which was confirmed by cone-beam computed tomography. The VA stenosis improved by flexing the neck and fixing the head position, following which the endovascular treatment was successfully completed. Conclusion: The site of the VA stenosis is critical in determining the etiology. Atherosclerotic VA stenosis often occurs at the origin of the artery or V4 segment, whereas bony compression-induced stenosis is more likely to occur at the V2 segment. Diagnosis and appropriate management of VA stenosis is based on determining the site.
27 July 2026 in Journal of Neurosurgery: Case Lessons
BACKGROUND: Neurofibromatosis type 1 (NF1) is a genetic disorder occasionally associated with vascular abnormalities, including arterial fragility and spontaneous rupture. Cervical hemorrhage related to NF1 is rare, yet potentially life-threatening, and its management presents significant challenges. Here, the authors report a rare case of NF1 complicated by recurrent spontaneous cervical hemorrhage requiring repeated endovascular embolization. OBSERVATION: A 67-year-old man with NF1 presented with acute cervical swelling without a history of trauma. CT revealed a large cervical hematoma causing tracheal deviation, and CT angiography showed active extravasation from a branch of the thyrocervical artery. Emergency endovascular embolization using n -butyl-2-cyanoacrylate achieved hemostasis. The following day, recurrent hemorrhage developed from branches of the transverse cervical and internal thoracic arteries, necessitating repeat endovascular embolization. After the second intervention, no further bleeding occurred, and the patient recovered with supportive care. LESSONS: In patients with NF1, cervical hemorrhage may recur early from a vascular territory distinct from the initially treated lesion. Even after a technically successful embolization, close early surveillance is required. https://thejns.org/doi/10.3171/CASE26354